These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38820123)

  • 1. Discovery and Validation of a Volatile Signature of Eosinophilic Airway Inflammation in Asthma.
    Peltrini R; Cordell RL; Wilde M; Abuhelal S; Quek E; Zounemat-Kermani N; Ibrahim W; Richardson M; Brinkman P; Schleich F; Stefanuto PH; Aung H; Greening N; Dahlen SE; Djukanovic R; Adcock IM; Brightling C; Monks P; Siddiqui S
    Am J Respir Crit Care Med; 2024 May; ():. PubMed ID: 38820123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled Volatile Organic Compounds Are Able to Discriminate between Neutrophilic and Eosinophilic Asthma.
    Schleich FN; Zanella D; Stefanuto PH; Bessonov K; Smolinska A; Dallinga JW; Henket M; Paulus V; Guissard F; Graff S; Moermans C; Wouters EFM; Van Steen K; van Schooten FJ; Focant JF; Louis R
    Am J Respir Crit Care Med; 2019 Aug; 200(4):444-453. PubMed ID: 30973757
    [No Abstract]   [Full Text] [Related]  

  • 3. Volatile organic compounds in a headspace sampling system and asthmatics sputum samples.
    Peltrini R; Cordell RL; Ibrahim W; Wilde MJ; Salman D; Singapuri A; Hargadon B; Brightling CE; Thomas CLP; Monks PS; Siddiqui S
    J Breath Res; 2021 Jan; 15(2):. PubMed ID: 33227714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma.
    Liu T; Wu J; Zhao J; Wang J; Zhang Y; Liu L; Cao L; Liu Y; Dong L
    Respir Med; 2015 Nov; 109(11):1391-6. PubMed ID: 26459159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.
    Jia G; Erickson RW; Choy DF; Mosesova S; Wu LC; Solberg OD; Shikotra A; Carter R; Audusseau S; Hamid Q; Bradding P; Fahy JV; Woodruff PG; Harris JM; Arron JR;
    J Allergy Clin Immunol; 2012 Sep; 130(3):647-654.e10. PubMed ID: 22857879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.
    Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N
    Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods to Detect Volatile Organic Compounds for Breath Biopsy Using Solid-Phase Microextraction and Gas Chromatography-Mass Spectrometry.
    Schulz E; Woollam M; Grocki P; Davis MD; Agarwal M
    Molecules; 2023 Jun; 28(11):. PubMed ID: 37299010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma.
    Wagener AH; de Nijs SB; Lutter R; Sousa AR; Weersink EJ; Bel EH; Sterk PJ
    Thorax; 2015 Feb; 70(2):115-20. PubMed ID: 25422384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
    Kulkarni NS; Hollins F; Sutcliffe A; Saunders R; Shah S; Siddiqui S; Gupta S; Haldar P; Green R; Pavord I; Wardlaw A; Brightling CE
    J Allergy Clin Immunol; 2010 Jul; 126(1):61-9.e3. PubMed ID: 20639010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD.
    Gao J; Zhang M; Zhou L; Yang X; Wu H; Zhang J; Wu F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1287-1293. PubMed ID: 28490872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled Volatile Organic Compounds for Asthma Control Classification in Children with Moderate to Severe Asthma: Results from the SysPharmPediA Study.
    Shahbazi Khamas S; Van Dijk Y; Abdel-Aziz MI; Neerincx AH; Blankestijn JM; Vijverberg SJH; Hashimoto S; Bush A; Kraneveld AD; Hedman AM; Toncheva AA; Almqvist C; Wolff C; Murray CS; Hedlin G; Roberts G; Adcock IM; Korta-Murua J; Bønnelykke K; Fleming LJ; Pino-Yanes M; Gorenjak M; Kabesch M; Sardón-Prado O; Montuschi P; Singer F; Corcuera-Elosegui P; Fowler SJ; Brandstetter S; Harner S; Dahlén SE; Potočnik U; Frey U; van Aalderen W; Brinkman P; Maitland-van der Zee AH
    Am J Respir Crit Care Med; 2024 Apr; ():. PubMed ID: 38648186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin.
    Pavlidis S; Takahashi K; Ng Kee Kwong F; Xie J; Hoda U; Sun K; Elyasigomari V; Agapow P; Loza M; Baribaud F; Chanez P; Fowler SJ; Shaw DE; Fleming LJ; Howarth PH; Sousa AR; Corfield J; Auffray C; De Meulder B; Knowles R; Sterk PJ; Guo Y; Adcock IM; Djukanovic R; Fan Chung K;
    Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30578390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive phenotyping using exhaled volatile organic compounds in asthma.
    Ibrahim B; Basanta M; Cadden P; Singh D; Douce D; Woodcock A; Fowler SJ
    Thorax; 2011 Sep; 66(9):804-9. PubMed ID: 21749985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study.
    Suzukawa M; Ohta K; Sugimoto M; Ohshima N; Kobayashi N; Tashimo H; Tanimoto Y; Itano J; Kimura G; Takata S; Nakano T; Yamashita T; Ikegame S; Hyodo K; Abe M; Chibana K; Kamide Y; Sasaki K; Hashimoto H
    Allergol Int; 2024 Oct; 73(4):524-531. PubMed ID: 38658257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both fractional exhaled nitric oxide and sputum eosinophil were associated with uncontrolled asthma.
    Gao J; Chen Z; Jie X; Ye R; Wu F
    J Asthma Allergy; 2018; 11():73-79. PubMed ID: 29692617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Sputum Eosinophilia With Easily Measured Type-2 Inflammatory Biomarkers in Untreated Mild Persistent Asthma.
    Covar R; Lazarus SC; Krishnan JA; Blake KV; Sorkness CA; Dyer AM; Lang JE; Lugogo NL; Mauger DT; Wechsler ME; Wenzel SE; Cardet JC; Castro M; Israel E; Phipatanakul W; King TS;
    J Allergy Clin Immunol Pract; 2024 Apr; 12(4):960-969.e6. PubMed ID: 38097180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we predict sputum eosinophilia from clinical assessment in patients referred to an adult asthma clinic?
    Yap E; Chua WM; Jayaram L; Zeng I; Vandal AC; Garrett J
    Intern Med J; 2013 Jan; 43(1):46-52. PubMed ID: 21790924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting steroid responsiveness in patients with asthma using exhaled breath profiling.
    van der Schee MP; Palmay R; Cowan JO; Taylor DR
    Clin Exp Allergy; 2013 Nov; 43(11):1217-25. PubMed ID: 24152154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of breath volatile organic compounds in acute cardiorespiratory breathlessness: a protocol describing a prospective real-world observational study.
    Ibrahim W; Wilde M; Cordell R; Salman D; Ruszkiewicz D; Bryant L; Richardson M; Free RC; Zhao B; Yousuf A; White C; Russell R; Jones S; Patel B; Awal A; Phillips R; Fowkes G; McNally T; Foxon C; Bhatt H; Peltrini R; Singapuri A; Hargadon B; Suzuki T; Ng LL; Gaillard E; Beardsmore C; Ryanna K; Pandya H; Coates T; Monks PS; Greening N; Brightling CE; Thomas P; Siddiqui S
    BMJ Open; 2019 Mar; 9(3):e025486. PubMed ID: 30852546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air.
    Delfino RJ; Gong H; Linn WS; Hu Y; Pellizzari ED
    J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):348-63. PubMed ID: 12973363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.